Forte Biosciences, Inc. (FBRX): Price and Financial Metrics


Forte Biosciences, Inc. (FBRX): $1.55

0.01 (+0.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FBRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 465

in industry

FBRX Stock Price Chart Interactive Chart >

Price chart for FBRX

FBRX Price/Volume Stats

Current price $1.55 52-week high $7.26
Prev. close $1.54 52-week low $1.50
Day low $1.50 Volume 211,237
Day high $1.64 Avg. volume 252,890
50-day MA $2.39 Dividend yield N/A
200-day MA $4.25 Market Cap 22.87M

Forte Biosciences, Inc. (FBRX) Company Bio


Forte Biosciences Inc. operates as a clinical-stage dermatology company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company is based in Torrance, California.


FBRX Latest News Stream


Event/Time News Detail
Loading, please wait...

FBRX Latest Social Stream


Loading social stream, please wait...

View Full FBRX Social Stream

Latest FBRX News From Around the Web

Below are the latest news stories about Forte Biosciences Inc that investors may wish to consider to help them evaluate FBRX as an investment opportunity.

Here's Why We're Watching Forte Biosciences' (NASDAQ:FBRX) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | December 15, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forte Biosciences, Inc. – FBRX

NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Forte Biosciences, Inc. (“Forte” or the “Company”) (NASDAQ: FBRX). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The investigation concerns whether Forte and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class acti

Yahoo | September 9, 2021

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, September 08, 2021--ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Forte Biosciences, Inc.

Yahoo | September 8, 2021

INVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Forte Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - September 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Forte Biosciences, Inc. ("Forte" or "the Company") (NASDAQ: FBRX) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Forte announced after the market closed on

Yahoo | September 6, 2021

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Forte Biosciences, Inc. (FBRX) Investigation

NEW YORK, NY / ACCESSWIRE / September 3, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Forte Biosciences, Inc. ("Forte" or the "Company") (NASDAQ:FBRX).

Yahoo | September 3, 2021

Read More 'FBRX' Stories Here

FBRX Price Returns

1-mo -28.90%
3-mo -45.04%
6-mo -69.32%
1-year -76.89%
3-year -93.00%
5-year N/A
YTD -27.57%
2021 -64.73%
2020 355.24%
2019 -93.51%
2018 -19.90%
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8466 seconds.